Filing Details
- Accession Number:
- 0001127602-17-025991
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-08-17 21:23:23
- Reporting Period:
- 2017-08-15
- Filing Date:
- 2017-08-17
- Accepted Time:
- 2017-08-17 21:23:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1110803 | Illumina Inc | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1189130 | T Jay Flatley | 5200 Illumina Way San Diego CA 92122 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-08-15 | 20,000 | $70.82 | 539,176 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-08-15 | 18,700 | $194.67 | 520,476 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-08-15 | 1,300 | $195.57 | 519,176 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2017-08-15 | 20,000 | $0.00 | 20,000 | $70.82 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 135,000 | 2011-03-01 | 2021-02-01 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 2,680 | Indirect | By Daughters |
Footnotes
- The sale was made pursuant to a 10b5-1 plan.
- Weighted average sale price representing 18,700 shares sold ranging from $194.28 to $195.24 per share. Number of shares sold at each separate price will be made available to thWeighted average sale price representing 18,700 shares sold ranging from $194.28 to $195.24 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.e SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 1,300 shares sold ranging from $195.39 to $195.76 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
Billionaire Hedge Funds
